| All participants | Participants who survived the follow-up | Participants who died during the follow-up |  |
---|---|---|---|---|
Characteristics | (n = 3,928) | (n = 3,091) | (n = 837) | Pb |
Leukocyte mitochondrial DNA copy number, median (interquartile range) | 72.00 (59.00–87.25) | 73.00 (60.00–88.50) | 68.00 (56.00–83.50) | .0094 |
High-sensitivity C-reactive protein, median (interquartile range), mg/L | 0.39 (0.16–0.83) | 0.38 (0.16–0.80) | 0.46 (0.17–0.94) |  < .0001 |
Age, years | 69.1 (8.1) | 67.4 (7.3) | 75.4 (7.9) |  < .0001 |
Women, n (%) | 2060 (52.4) | 1728 (55.9) | 332 (39.7) |  < .0001 |
Education | ||||
 Illiteracy, n (%) | 370 (9.4) | 243 (7.9) | 127 (15.2) |  < .0001 |
 Elementary school, n (%) | 1667 (42.4) | 1264 (40.9) | 403 (48.2) | |
 Junior high school | 447 (11.4) | 355 (11.5) | 92 (11.0) | |
 ≥ High school, n (%) | 1444 (36.8) | 1229 (39.8) | 215 (25.7) | |
Smoking | ||||
 Never, n (%) | 2830 (72.1) | 2337 (75.6) | 493 (58.9) |  < .0001 |
 Former smoker, n (%) | 634 (16.1) | 434 (14.0) | 200 (23.9) | |
 Current smoker, n (%) | 464 (11.8) | 320 (10.4) | 144 (17.2) | |
Body mass index, kg/m2 | 24.2 (3.3) | 24.3 (3.3) | 24 (3.6) | .0089 |
Serum triglycerides, mg/dL | 119.1 (78.8) | 120 (81.4) | 115.9 (68.4) | .1822 |
Serum high-density lipoprotein cholesterol, mg/dL | 53.5 (13.9) | 53.9 (13.7) | 52.2 (14.4) | .0013 |
Serum low-density lipoprotein cholesterol, mg/dL | 116.6 (32.0) | 118.2 (31.4) | 110.4 (33.4) |  < .0001 |
Hypertension, n (%) | 1988 (50.6) | 1443 (46.7) | 545 (65.1) |  < .0001 |
Diabetes mellitus, n (%) | 1021 (26.0) | 708 (22.9) | 313 (37.4) |  < .0001 |
Cardiovascular disease, n (%) | 799 (20.3) | 577 (18.7) | 222 (26.5) |  < .0001 |
Stroke, n (%) | 188 (4.8) | 100 (3.2) | 88 (10.5) |  < .0001 |
Lung disease, n (%) | 116 (3.0) | 72 (2.3) | 44 (5.3) |  < .0001 |
Chronic kidney disease, n (%) | 559 (14.2) | 295 (9.5) | 264 (31.5) |  < .0001 |
Years of observation, years, median (interquartile range) | 10.6 (9.1–11.6) | 11.1 (9.6–12.0) | 7.0 (4.7–9.1) |  < .0001 |